Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
Cancer Treatment Reviews, 04/03/2012Murray S et al.
Currently no valid practical biomarkers exist that can predict resistance to the taxanes in breast cancer supporting the principle of individualized cancer therapy. The incorporation of several biomarker analyses into prospectively designed studies in this setting are needed.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.